SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-012921
Filing Date
2023-04-19
Accepted
2023-04-19 16:45:26
Documents
14
Period of Report
2023-04-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46173
2 ex5-1.htm EX-5.1 9768
3 ex10-1.htm EX-10.1 242646
  Complete submission text file 0001493152-23-012921.txt   538111

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20230419.xsd EX-101.SCH 3227
5 XBRL LABEL FILE aim-20230419_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE aim-20230419_pre.xml EX-101.PRE 22790
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3655
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 23830492
SIC: 2836 Biological Products, (No Diagnostic Substances)